Concepedia

Fernando Doñate

FD

36

Publications

3.1K

Citations

25

H-Index

1994

Active since

Affiliations

D. E. Shaw Research(Current)

University of Santa Monica

Astellas Pharma (United States)

Princess Margaret Cancer Centre

Case Western Reserve University

Fernando Doñate is an author at D. E. Shaw Research specializing in medicine, pharmacology, and cell biology.

ORCID

Top concepts

Publications per year

1994–2020

36

Publications

36

Enfortumab Vedotin Antibody–Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models

Pia M. Challita-Eid, Daulet Satpayev, Peng Yang et al. · Cancer Research · 2016 · 669 citations

Superoxide dismutase 1 (SOD1) is essential for H <sub>2</sub> O <sub>2</sub> -mediated oxidation and inactivation of phosphatases in growth factor signaling

Jose C. Juarez, Mari Manuia, Mark E. Burnett et al. · Proceedings of the National Academy of Sciences · 2008 · 255 citations · Full text

, , +17

A non–RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis <i>in vivo</i>

Parisa Khalili, Ani Arakelian, Gaoping Chen et al. · Molecular Cancer Therapeutics · 2006 · 196 citations · Full text

The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3

Christopher P. Guise, Maria R. Abbattista, Rachelle S. Singleton et al. · Cancer Research · 2010 · 185 citations · Full text

, , +15

Copper Binding by Tetrathiomolybdate Attenuates Angiogenesis and Tumor Cell Proliferation through the Inhibition of Superoxide Dismutase 1

Jose C. Juarez, Oscar Betancourt, Steven Pirie‐Shepherd et al. · Clinical Cancer Research · 2006 · 161 citations

Rows per page

1–5 of 36